The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus

被引:23
作者
Ravassa, Susana [1 ]
Barba, Joaquin [2 ]
Coma-Canella, Isabel [2 ]
Huerta, Ana [3 ]
Lopez, Begona [1 ]
Gonzalez, Arantxa [1 ]
Diez, Javier [1 ,2 ]
机构
[1] Univ Navarra, Ctr Appl Med Res, Div Cardiovasc Sci, E-31080 Pamplona, Spain
[2] Univ Navarra, Univ Navarra Clin, Dept Cardiol & Cardiac Surg, E-31080 Pamplona, Spain
[3] Univ Navarra, Univ Navarra Clin, Dept Internal Med, E-31080 Pamplona, Spain
来源
CARDIOVASCULAR DIABETOLOGY | 2013年 / 12卷
关键词
Dipeptidyl peptidase-4; Type 2 diabetes mellitus; Subclinical left ventricular dysfunction; CHRONIC HEART-FAILURE; IV ACTIVITY; CARDIOVASCULAR RISK; DIASTOLIC FUNCTION; EUROPEAN-SOCIETY; GLUCOSE CONTROL; NT-PROBNP; INHIBITION; METFORMIN; BENCH;
D O I
10.1186/1475-2840-12-143
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with type 2 diabetes mellitus (T2DM) present subclinical left ventricular systolic and/or diastolic dysfunction (LVD). Dipeptidyl peptidase-4 (DPP4) inactivates peptides that possess cardioprotective actions. Our aim was to analyze whether the activity of circulating DPP4 is associated with echocardiographically defined LVD in asymptomatic patients with T2DM. Methods: In this cross-sectional study, we examined 83 T2DM patients with no coronary or valve heart disease and 59 age and gender-matched non-diabetic subjects. Plasma DPP4 activity (DPP4a) was measured by enzymatic assay and serum amino-terminal pro-brain natriuretic peptide (NT-proBNP) was measured by enzyme-linked immunosorbent assay. LV function was assessed by two-dimensional echocardiographic imaging, targeted M-mode recordings and Doppler ultrasound measurements. Differences in means were assessed by t-tests and one-way ANOVA. Associations were assessed by adjusted multiple linear regression and logistic regression analyses. Results: DPP4a was increased in T2DM patients as compared with non-diabetic subjects (5855 +/- 1632 vs 5208 +/- 957 pmol/min/mL, p < 0.05). Clinical characteristics and echocardiographic parameters assessing LV morphology were similar across DPP4a tertiles in T2DM patients. However, prevalence of LVD progressively increased across incremental DPP4a tertiles (13%, 39% and 71%, all p < 0.001). Multivariate regression analysis confirmed the independent associations of DPP4a with LVD in T2DM patients (p < 0.05). Similarly, multiple logistic regression analysis showed that an increase of 100 pmol/min/min plasma DPP4a was independently associated with an increased frequency of LVD with an adjusted odds ratio of 1.10 (95% CI, 1.04 to 1.15, p = 0.001). Conclusions: An excessive activity of circulating DPP4 is independently associated with subclinical LVD in T2DM patients. Albeit descriptive, these findings suggest that DPP4 may be involved in the mechanisms of LVD in T2DM.
引用
收藏
页数:11
相关论文
共 50 条
[41]   Cardiovascular effects of gliptins [J].
Scheen, Andre J. .
NATURE REVIEWS CARDIOLOGY, 2013, 10 (02) :73-84
[42]   A review of gliptins in 2011 [J].
Scheen, Andre J. .
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (01) :81-99
[43]   Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus [J].
Scirica, Benjamin M. ;
Bhatt, Deepak L. ;
Braunwald, Eugene ;
Steg, P. Gabriel ;
Davidson, Jaime ;
Hirshberg, Boaz ;
Ohman, Peter ;
Frederich, Robert ;
Wiviott, Stephen D. ;
Hoffman, Elaine B. ;
Cavender, Matthew A. ;
Udell, Jacob A. ;
Desai, Nihar R. ;
Mosenzon, Ofri ;
McGuire, Darren K. ;
Ray, Kausik K. ;
Leiter, Lawrence A. ;
Raz, Itamar ;
Braunwald, Eugene ;
Bhatt, Deepak L. ;
Scirica, Benjamin M. ;
Udell, Jacob A. ;
Cavender, Matthew A. ;
Desai, Nihar ;
Abrahamsen, Timothy ;
Grossman, Michelle ;
Morin, Suzanne ;
Im, Kyungah ;
Hoffman, Elaine ;
Gabovitch, Daniel ;
Pricken, Alexandra ;
Mosenzon, Ofri ;
Buskila, Alona ;
Ohman, Peter ;
Hirshberg, Boaz ;
Stahre, Christina ;
Price, Deborah ;
Billing-Clason, Solveig ;
Sabel, Karin ;
Monyak, John ;
Sjostrand, Mikalea ;
Wei, Cheryl ;
Lu, Jane ;
Miller, Elinor ;
Raichlen, Joel ;
Fitt, Sandy ;
Frederich, Robert ;
Iqbal, Nayyar ;
Donovan, Mark ;
Davidson, Jaime A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14) :1317-1326
[44]   Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions [J].
Shigeta, Toshimasa ;
Aoyama, Morihiko ;
Bando, Yasuko K. ;
Monji, Akio ;
Mitsui, Toko ;
Takatsu, Miwa ;
Cheng, Xiang-Wu ;
Okumura, Takahiro ;
Hirashiki, Akihiro ;
Nagata, Kohzo ;
Murohara, Toyoaki .
CIRCULATION, 2012, 126 (15) :1838-U155
[45]   Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice [J].
Takahashi, Ayako ;
Asakura, Masanori ;
Ito, Shin ;
Min, Kyung-Duk ;
Shindo, Kazuhiro ;
Yan, Yi ;
Liao, Yulin ;
Yamazaki, Satoru ;
Sanada, Shoji ;
Asano, Yoshihiro ;
Ishibashi-Ueda, Hatsue ;
Takashima, Seiji ;
Minamino, Tetsuo ;
Asanuma, Hiroshi ;
Mochizuki, Naoki ;
Kitakaze, Masafumi .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2013, 304 (10) :H1361-H1369
[46]   Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitus [J].
Thondam, S. K. ;
Cross, A. ;
Cuthbertson, D. J. ;
Wilding, J. P. ;
Daousi, C. .
DIABETIC MEDICINE, 2012, 29 (08) :E205-E210
[47]   Cardiovascular Biology of the Incretin System [J].
Ussher, John R. ;
Drucker, Daniel J. .
ENDOCRINE REVIEWS, 2012, 33 (02) :187-215
[48]   Dipeptidyl-peptidase IV and B-type natriuretic peptide. From bench to bedside [J].
Vanderheyden, Marc ;
Bartunek, Jozef ;
Goethals, Marc ;
Verstreken, Sofie ;
Lambeir, Anne-Marie ;
De Meester, Ingrid ;
Scharpe, Simon .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (03) :248-252
[49]   Progression of Subclinical Myocardial Dysfunction in Type 2 Diabetes after 5 years Despite Improved Glycemic Control [J].
Vintila, Vlad Damian ;
Roberts, Aled ;
Vinereanu, Dragos ;
Fraser, Alan Gordon .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2012, 29 (09) :1045-1053
[50]   An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease [J].
Zhong, Jixin ;
Rao, Xiaoquan ;
Rajagopalan, Sanjay .
ATHEROSCLEROSIS, 2013, 226 (02) :305-314